Anika Therapeutics, Inc. (ANIK)
USD 16.04
(-3.49%)
USD 16.04
(-3.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 58.36 Million USD | -8.18% |
| 2022 | 63.56 Million USD | 5.15% |
| 2021 | 60.45 Million USD | -35.14% |
| 2020 | 93.2 Million USD | 120.18% |
| 2019 | 42.33 Million USD | 175.22% |
| 2018 | 15.38 Million USD | -19.58% |
| 2017 | 19.12 Million USD | 9.46% |
| 2016 | 17.47 Million USD | -29.83% |
| 2015 | 24.9 Million USD | 56.61% |
| 2014 | 15.89 Million USD | -22.09% |
| 2013 | 20.4 Million USD | -38.43% |
| 2012 | 33.14 Million USD | -12.97% |
| 2011 | 38.08 Million USD | -12.95% |
| 2010 | 43.74 Million USD | -9.91% |
| 2009 | 48.55 Million USD | 38.48% |
| 2008 | 35.06 Million USD | 42.91% |
| 2007 | 24.53 Million USD | 8.44% |
| 2006 | 22.62 Million USD | -8.49% |
| 2005 | 24.72 Million USD | -15.25% |
| 2004 | 29.17 Million USD | 650.19% |
| 2003 | 3.88 Million USD | 28.67% |
| 2002 | 3.02 Million USD | 7.49% |
| 2001 | 2.81 Million USD | 24.08% |
| 2000 | 2.26 Million USD | -66.67% |
| 1999 | 6.8 Million USD | 172.0% |
| 1998 | 2.5 Million USD | 0.0% |
| 1997 | 2.5 Million USD | 31.58% |
| 1996 | 1.9 Million USD | -13.64% |
| 1995 | 2.2 Million USD | -4.35% |
| 1994 | 2.3 Million USD | -20.69% |
| 1993 | 2.9 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 52.31 Million USD | -5.24% |
| 2024 Q1 | 55.2 Million USD | -5.41% |
| 2024 Q3 | 51.54 Million USD | -1.48% |
| 2023 Q2 | 54.86 Million USD | -10.77% |
| 2023 Q1 | 61.48 Million USD | -3.27% |
| 2023 FY | 58.36 Million USD | -8.18% |
| 2023 Q4 | 58.36 Million USD | 1.21% |
| 2023 Q3 | 57.67 Million USD | 5.11% |
| 2022 FY | 63.56 Million USD | 5.15% |
| 2022 Q4 | 63.56 Million USD | 1.2% |
| 2022 Q2 | 67.97 Million USD | 20.4% |
| 2022 Q1 | 56.45 Million USD | -6.61% |
| 2022 Q3 | 62.8 Million USD | -7.59% |
| 2021 Q4 | 60.45 Million USD | -3.85% |
| 2021 FY | 60.45 Million USD | -35.14% |
| 2021 Q1 | 85.59 Million USD | -8.16% |
| 2021 Q2 | 76.32 Million USD | -10.83% |
| 2021 Q3 | 62.87 Million USD | -17.63% |
| 2020 Q1 | 105.16 Million USD | 148.42% |
| 2020 Q2 | 152.08 Million USD | 44.62% |
| 2020 Q3 | 131.88 Million USD | -13.28% |
| 2020 Q4 | 93.2 Million USD | -29.33% |
| 2020 FY | 93.2 Million USD | 120.18% |
| 2019 Q2 | 36.41 Million USD | -3.11% |
| 2019 Q1 | 37.58 Million USD | 144.38% |
| 2019 Q4 | 42.33 Million USD | 11.7% |
| 2019 Q3 | 37.89 Million USD | 4.06% |
| 2019 FY | 42.33 Million USD | 175.22% |
| 2018 Q3 | 13.99 Million USD | -25.58% |
| 2018 Q2 | 18.81 Million USD | -8.55% |
| 2018 FY | 15.38 Million USD | -19.58% |
| 2018 Q1 | 20.57 Million USD | 7.55% |
| 2018 Q4 | 15.38 Million USD | 9.87% |
| 2017 Q4 | 19.12 Million USD | -3.61% |
| 2017 Q2 | 20.86 Million USD | 20.34% |
| 2017 Q3 | 19.84 Million USD | -4.9% |
| 2017 Q1 | 17.33 Million USD | -0.77% |
| 2017 FY | 19.12 Million USD | 9.46% |
| 2016 Q2 | 18.32 Million USD | -4.02% |
| 2016 Q3 | 16.51 Million USD | -9.84% |
| 2016 FY | 17.47 Million USD | -29.83% |
| 2016 Q1 | 19.08 Million USD | -23.34% |
| 2016 Q4 | 17.47 Million USD | 5.78% |
| 2015 Q4 | 24.9 Million USD | 7.81% |
| 2015 Q3 | 23.09 Million USD | 32.4% |
| 2015 FY | 24.9 Million USD | 56.61% |
| 2015 Q1 | 15.86 Million USD | -0.19% |
| 2015 Q2 | 17.44 Million USD | 9.93% |
| 2014 Q3 | 15.79 Million USD | -5.44% |
| 2014 Q2 | 16.7 Million USD | -4.51% |
| 2014 Q4 | 15.89 Million USD | 0.67% |
| 2014 Q1 | 17.49 Million USD | -14.29% |
| 2014 FY | 15.89 Million USD | -22.09% |
| 2013 Q1 | 28.53 Million USD | -13.92% |
| 2013 Q4 | 20.4 Million USD | -28.83% |
| 2013 Q3 | 28.67 Million USD | -0.98% |
| 2013 Q2 | 28.96 Million USD | 1.51% |
| 2013 FY | 20.4 Million USD | -38.43% |
| 2012 FY | 33.14 Million USD | -12.97% |
| 2012 Q2 | 35.62 Million USD | 1.89% |
| 2012 Q4 | 33.14 Million USD | 5.56% |
| 2012 Q3 | 31.39 Million USD | -11.87% |
| 2012 Q1 | 34.96 Million USD | -8.18% |
| 2011 FY | 38.08 Million USD | -12.95% |
| 2011 Q4 | 38.08 Million USD | 3.13% |
| 2011 Q3 | 36.92 Million USD | -8.28% |
| 2011 Q2 | 40.25 Million USD | -2.17% |
| 2011 Q1 | 41.14 Million USD | -5.94% |
| 2010 FY | 43.74 Million USD | -9.91% |
| 2010 Q2 | 44.29 Million USD | -3.63% |
| 2010 Q3 | 45.47 Million USD | 2.67% |
| 2010 Q1 | 45.96 Million USD | -5.35% |
| 2010 Q4 | 43.74 Million USD | -3.8% |
| 2009 Q3 | 32.14 Million USD | -3.8% |
| 2009 FY | 48.55 Million USD | 38.48% |
| 2009 Q2 | 33.41 Million USD | -1.84% |
| 2009 Q1 | 34.04 Million USD | -2.92% |
| 2009 Q4 | 48.55 Million USD | 51.06% |
| 2008 Q3 | 29.01 Million USD | -4.91% |
| 2008 Q4 | 35.06 Million USD | 20.84% |
| 2008 FY | 35.06 Million USD | 42.91% |
| 2008 Q1 | 26.08 Million USD | 6.32% |
| 2008 Q2 | 30.51 Million USD | 16.97% |
| 2007 Q4 | 24.53 Million USD | -14.23% |
| 2007 Q2 | 25.31 Million USD | 15.73% |
| 2007 Q1 | 21.87 Million USD | -3.31% |
| 2007 Q3 | 28.6 Million USD | 12.99% |
| 2007 FY | 24.53 Million USD | 8.44% |
| 2006 FY | 22.62 Million USD | -8.49% |
| 2006 Q2 | 24.6 Million USD | 7.05% |
| 2006 Q3 | 24.56 Million USD | -0.14% |
| 2006 Q4 | 22.62 Million USD | -7.91% |
| 2006 Q1 | 22.98 Million USD | -7.05% |
| 2005 Q2 | 25.2 Million USD | -8.81% |
| 2005 Q3 | 25.75 Million USD | 2.2% |
| 2005 Q4 | 24.72 Million USD | -4.0% |
| 2005 Q1 | 27.63 Million USD | -5.28% |
| 2005 FY | 24.72 Million USD | -15.25% |
| 2004 Q1 | 26.91 Million USD | 592.11% |
| 2004 Q4 | 29.17 Million USD | 11.44% |
| 2004 Q3 | 26.18 Million USD | 9.82% |
| 2004 Q2 | 23.84 Million USD | -11.43% |
| 2004 FY | 29.17 Million USD | 650.19% |
| 2003 Q4 | 3.88 Million USD | 49.4% |
| 2003 Q1 | 2.59 Million USD | -14.11% |
| 2003 Q2 | 2.13 Million USD | -17.76% |
| 2003 FY | 3.88 Million USD | 28.67% |
| 2003 Q3 | 2.6 Million USD | 21.92% |
| 2002 FY | 3.02 Million USD | 7.49% |
| 2002 Q4 | 3.02 Million USD | -14.2% |
| 2002 Q3 | 3.52 Million USD | 14.64% |
| 2002 Q1 | 2.8 Million USD | -0.33% |
| 2002 Q2 | 3.07 Million USD | 9.64% |
| 2001 FY | 2.81 Million USD | 24.08% |
| 2001 Q1 | 2.36 Million USD | 4.35% |
| 2001 Q2 | 3.77 Million USD | 59.44% |
| 2001 Q3 | 3.26 Million USD | -13.3% |
| 2001 Q4 | 2.81 Million USD | -13.98% |
| 2000 Q4 | 2.26 Million USD | -64.12% |
| 2000 Q1 | 7.33 Million USD | 7.86% |
| 2000 FY | 2.26 Million USD | -66.67% |
| 2000 Q2 | 7.31 Million USD | -0.32% |
| 2000 Q3 | 6.31 Million USD | -13.61% |
| 1999 Q4 | 6.8 Million USD | 209.09% |
| 1999 FY | 6.8 Million USD | 172.0% |
| 1999 Q3 | 2.2 Million USD | -8.33% |
| 1999 Q1 | 2.7 Million USD | 8.0% |
| 1999 Q2 | 2.4 Million USD | -11.11% |
| 1998 Q3 | 2 Million USD | -4.76% |
| 1998 Q1 | 2.3 Million USD | -8.0% |
| 1998 Q2 | 2.1 Million USD | -8.7% |
| 1998 Q4 | 2.5 Million USD | 25.0% |
| 1998 FY | 2.5 Million USD | 0.0% |
| 1997 Q3 | 2.2 Million USD | 10.0% |
| 1997 Q1 | 1.6 Million USD | 0.0% |
| 1997 FY | 2.5 Million USD | 31.58% |
| 1997 Q2 | 2 Million USD | 25.0% |
| 1997 Q4 | 2.5 Million USD | 13.64% |
| 1996 Q4 | 1.6 Million USD | -5.88% |
| 1996 Q2 | 1.7 Million USD | -32.0% |
| 1996 Q1 | 2.5 Million USD | 8.7% |
| 1996 FY | 1.9 Million USD | -13.64% |
| 1996 Q3 | 1.7 Million USD | 0.0% |
| 1995 Q3 | 2.2 Million USD | -12.0% |
| 1995 Q4 | 2.3 Million USD | 4.55% |
| 1995 Q1 | 2 Million USD | -4.76% |
| 1995 Q2 | 2.5 Million USD | 25.0% |
| 1995 FY | 2.2 Million USD | -4.35% |
| 1994 FY | 2.3 Million USD | -20.69% |
| 1994 Q1 | 2.2 Million USD | -18.52% |
| 1994 Q3 | 2.3 Million USD | -4.17% |
| 1994 Q4 | 2.1 Million USD | -8.7% |
| 1994 Q2 | 2.4 Million USD | 9.09% |
| 1993 FY | 2.9 Million USD | 0.0% |
| 1993 Q3 | 2.9 Million USD | 31.82% |
| 1993 Q2 | 2.2 Million USD | 0.0% |
| 1993 Q4 | 2.7 Million USD | -6.9% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | -6.433% |
| Axonics, Inc. | 82.35 Million USD | 29.131% |
| INVO Bioscience, Inc. | 19.99 Million USD | -191.909% |
| CVRx, Inc. | 39.28 Million USD | -48.585% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 73.832% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -1734.319% |
| MaxCyte, Inc. | 36.1 Million USD | -61.65% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -171.626% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 52.917% |
| Sintx Technologies, Inc. | 6.59 Million USD | -785.287% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -13.878% |
| Apyx Medical Corporation | 52.31 Million USD | -11.562% |
| Cutera, Inc. | 518.12 Million USD | 88.735% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -992.606% |
| NeuroPace, Inc. | 86.99 Million USD | 32.909% |
| IRIDEX Corporation | 24.91 Million USD | -134.274% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 33.52% |
| enVVeno Medical Corporation | 2.43 Million USD | -2297.002% |
| TELA Bio, Inc. | 59.16 Million USD | 1.352% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 90.866% |
| UFP Technologies, Inc. | 118.04 Million USD | 50.555% |
| Modular Medical, Inc. | 2.27 Million USD | -2468.97% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -99.015% |
| LENSAR, Inc. | 22.4 Million USD | -160.462% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 97.34% |
| Surmodics, Inc. | 65.82 Million USD | 11.327% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -465.627% |
| Inogen, Inc. | 121.38 Million USD | 51.915% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -3386.679% |
| RxSight, Inc. | 22.18 Million USD | -163.057% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -13624.338% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -97.312% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -152.3% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -13624.338% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -2302.626% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 44.202% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 91.703% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -129.223% |
| Dynatronics Corporation | 11.78 Million USD | -395.471% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -12.976% |
| InMode Ltd. | 75.91 Million USD | 23.114% |
| Bruker Corporation | 2.83 Billion USD | 97.942% |
| Movano Inc. | 5.97 Million USD | -877.344% |
| Orthofix Medical Inc. | 326.58 Million USD | 82.128% |
| FONAR Corporation | 57.45 Million USD | -1.583% |
| BioSig Technologies, Inc. | 4.68 Million USD | -1145.827% |
| Envoy Medical, Inc. | 9.4 Million USD | -520.793% |
| Align Technology, Inc. | 2.45 Billion USD | 97.621% |
| Talis Biomedical Corporation | 29.22 Million USD | -99.723% |
| Cerus Corporation | 144.3 Million USD | 59.553% |
| 908 Devices Inc. | 37.49 Million USD | -55.687% |
| Nemaura Medical Inc. | 26.37 Million USD | -121.276% |
| Outset Medical, Inc. | 190.91 Million USD | 69.428% |
| NanoVibronix, Inc. | 2.68 Million USD | -2073.008% |
| Venus Concept Inc. | 107.1 Million USD | 45.504% |
| Telesis Bio, Inc. | 40.87 Million USD | -42.801% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 48.787% |
| Quipt Home Medical Corp. | 136.29 Million USD | 57.175% |
| IRadimed Corporation | 20.73 Million USD | -181.478% |
| Tenon Medical, Inc. | 5.56 Million USD | -948.446% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1534.015% |
| Pulmonx Corporation | 60.63 Million USD | 3.742% |
| iCAD, Inc. | 8 Million USD | -629.496% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -359.927% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -3058.541% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -43.091% |
| SI-BONE, Inc. | 61.05 Million USD | 4.395% |
| Semler Scientific, Inc. | 6.27 Million USD | -830.893% |
| Biotricity, Inc. | 35.91 Million USD | -62.494% |
| Cytosorbents Corporation | 29.98 Million USD | -94.651% |
| DexCom, Inc. | 4.19 Billion USD | 98.609% |
| ZimVie Inc. | 795.85 Million USD | 92.666% |
| Aethlon Medical, Inc. | 2.47 Million USD | -2253.84% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -388.097% |
| IceCure Medical Ltd | 4.24 Million USD | -1274.311% |
| PAVmed Inc | 57.13 Million USD | -2.153% |
| Sight Sciences, Inc. | 46.43 Million USD | -25.693% |
| Insulet Corporation | 1.85 Billion USD | 96.854% |
| Profound Medical Corp. | 12.66 Million USD | -360.821% |
| electroCore, Inc. | 8.94 Million USD | -552.51% |
| Bioventus Inc. | 589.79 Million USD | 90.104% |
| InspireMD, Inc. | 8.14 Million USD | -616.863% |
| PAVmed Inc. | 57.13 Million USD | -2.153% |
| Nuwellis, Inc. | 6.78 Million USD | -760.87% |
| OrthoPediatrics Corp. | 72.56 Million USD | 19.561% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -388.097% |
| BrainsWay Ltd. | 15.31 Million USD | -281.135% |
| BIOLASE, Inc. | 35.34 Million USD | -65.121% |
| Beyond Air, Inc. | 29.77 Million USD | -96.027% |
| AxoGen, Inc. | 101.16 Million USD | 42.303% |
| Inari Medical, Inc. | 209.32 Million USD | 72.117% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -2570.266% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -3180.888% |
| AdaptHealth Corp. | 3.15 Billion USD | 98.149% |
| Quanterix Corporation | 78.08 Million USD | 25.251% |
| Viveve Medical, Inc. | 10.84 Million USD | -438.093% |
| LivaNova PLC | 1.15 Billion USD | 94.933% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -230.989% |
| Varex Imaging Corporation | 668.6 Million USD | 91.27% |
| Vivani Medical, Inc. | 25.03 Million USD | -133.132% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -1336.196% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -1534.015% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -1094.821% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 94.413% |
| TransMedics Group, Inc. | 568.84 Million USD | 89.739% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -249.88% |
| NeuroMetrix, Inc. | 1.33 Million USD | -4278.212% |
| Spectral AI, Inc. | 12.4 Million USD | -370.664% |
| Hyperfine, Inc. | 9.8 Million USD | -495.582% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 76.676% |
| Biomerica, Inc. | 2.66 Million USD | -2091.776% |
| Bone Biologics Corporation | 831.4 Thousand USD | -6920.31% |
| AVITA Medical, Inc. | 19.86 Million USD | -193.812% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -2857.263% |
| Silk Road Medical, Inc | 114.15 Million USD | 48.872% |